À retenir
In 88 UK adults with treatment-resistant depression, a ketogenic diet lowered PHQ-9 depression scores by 2.18 points more than a control diet at 6 weeks (95% CI -4.33 to -0.03; P = .05), but the gap was not clear at 12 weeks (P = .10). Both groups improved a lot, the trial was small and short, and the authors say the clinical relevance is uncertain.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Many people with depression do not respond to standard treatment, and animal studies and case reports hinted that ketogenic diets might help. The authors tested in a randomized trial whether a ketogenic diet reduces depression severity more than a well-matched control diet in adults with treatment-resistant depression.
Population et méthode
Randomized clinical trial run in the UK between February 22 and June 15, 2024, in adults aged 18 to 65 with treatment-resistant depression and a 9-item Patient Health Questionnaire (PHQ-9) score of 15 or greater. Participants were randomized 1:1 for 6 weeks to a ketogenic diet of prepared foods with less than 30 g of carbohydrates per day, or a control phytochemical diet (one extra serving of vegetables or fruit and swapping saturated for unsaturated fats), with weekly dietetic support in both. The primary outcome was the between-group difference in PHQ-9 change from baseline to week 6; follow-up ended at 12 weeks.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Depression scores fell in both arms: by 10.5 points (SD 7.0) on the ketogenic diet and 8.3 (SD 5.1) on the control diet at week 6.
- 2The between-group difference at 6 weeks was -2.18 PHQ-9 points (95% CI -4.33 to -0.03; P = .05; Cohen d -0.68), a borderline result that favored the ketogenic diet.
- 3At 12 weeks the difference was -1.85 (95% CI -4.04 to 0.33; P = .10; Cohen d -0.58), so the confidence interval included no difference.
- 4No differences were seen in secondary outcomes (remission, anxiety, anhedonia, cognition, quality of life, function), and no serious adverse events occurred.
Limites et incertitude
- 1Only 88 people took part (44 per group), and the primary result sits right at the edge of statistical significance, so it could shift with a larger trial.
- 2Follow-up was 6 weeks of diet plus follow-up to 12 weeks; long-term effects and the ability to stay on a ketogenic diet are not shown.
- 3Prepared foods and weekly dietetic support are far more than most people get at home, and participants could likely tell which diet they were on.
- 4The authors note the effect was modest and not evident in secondary analyses; this reading uses the abstract only.
Mise en perspective
Dietary change, including the control diet, was linked to meaningful drops in depressive symptoms, and the ketogenic diet added at most a modest extra benefit. Anyone with depression that has not responded to treatment should discuss diet changes with their clinician rather than replacing treatment with a diet.
Vos données
If you try a structured diet, keep a food log and note your mood on a regular questionnaire, such as PHQ-9, at the same time each week. Weight or sleep logs can add context, but they cannot tell you whether the diet is treating depression.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Importance
Preclinical evidence and case reports suggest potential therapeutic benefits of ketogenic diets (KDs) in the treatment of depression, but evidence from well-controlled randomized clinical trials (RCTs) is lacking.
Objective
To assess the efficacy of a KD compared with a control diet in adults with treatment-resistant depression (TRD).
Design, setting, and participants
This RCT was conducted between February 22 and June 15, 2024. Participants aged 18 to 65 years with TRD and a score of 15 or greater on the 9-item Patient Health Questionnaire (PHQ-9) from across the UK were included.
Intervention
Participants were randomized 1:1 to one of two 6-week dietary interventions: (1) KD of prepared foods providing less than 30 g of carbohydrates per day with weekly individual dietetic support or (2) a control (phytochemical [phyto]) diet with vouchers to purchase 1 extra serving of vegetables or fruit and replace saturated fats with unsaturated fats, with equal dietetic support. The last follow-up was at 12 weeks.
Main outcomes and measures
The primary outcome was the between-group difference in change in PHQ-9 score from baseline to week 6. Secondary outcomes included PHQ-9 score at 12 weeks, depression remission, anxiety, anhedonia, cognitive impairment, quality of life, and functional outcomes.
Results
The study included 88 participants (mean [SD] age, 42.1 [13.1] years; 61 women [69%]): 44 in the KD group and 44 in the phyto diet group. Depression severity decreased markedly in both groups; the mean (SD) change in PHQ-9 score from baseline to week 6 was -10.5 (7.0) in the KD group and -8.3 (5.1) in the phyto group. The mean between-group differences in PHQ-9 score at 6 and 12 weeks were -2.18 (95% CI, -4.33 to -0.03; P = .05; Cohen d, -0.68; 95% CI -1.35 to -0.01) and -1.85 (95% CI, -4.04 to 0.33; P = .10; Cohen d, -0.58; 95% CI, -1.26 to 0.10), respectively. There were no differences in secondary outcomes between the KD and phyto groups. No serious adverse events occurred.
Conclusions and relevance
In this RCT, a KD had antidepressant benefits compared with a well-matched control diet at 6 weeks. However, the clinical relevance is uncertain, as the mean effect size compared with the control was modest and not evident in secondary analyses.
Trial registration
ClinicalTrials.gov Identifier: NCT06091163.
Sources et attribution
A Ketogenic Diet for Treatment-Resistant Depression: A Randomized Clinical Trial.
Gao M, Kirk M, Knight H, Lash E, Michalopoulou M, Guess N, Stevens R, Browning M, Weich S, Burnet PWJ, Jebb SA, Aveyard P.
JAMA psychiatry · 2026-04-01
DOI: 10.1001/jamapsychiatry.2025.4431 ↗PubMed · 41637092 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

